Belmont Center for Comprehensive Treatment — Philadelphia, Pennsylvania

Belmont Center for Comprehensive Treatment is a clinical research site located in Philadelphia, Pennsylvania, United States 19131.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Belmont Center for Comprehensive Treatment has participated in 10 clinical trials.

Therapeutic areas: Smoking Cessation, Schizophrenia, Major Depressive Disorder.

Sponsors: Pfizer, Novartis, Shire.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Belmont Center for Comprehensive Treatment?

Belmont Center for Comprehensive Treatment has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Belmont Center for Comprehensive Treatment conducted?

Belmont Center for Comprehensive Treatment has 10 clinical trials on record. Their work covers Smoking Cessation, Schizophrenia, Major Depressive Disorder.

Is Belmont Center for Comprehensive Treatment accredited by Crixeo Health?

Yes — Belmont Center for Comprehensive Treatment holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Belmont Center for Comprehensive Treatment?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.